These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11775418

  • 1. [Late-appearing cholestatic icterus after a month of treatment with ticlopidine].
    Placci A, Melandri G, Cecilioni L, Valgimigli M, Bolondi L, Branzi A.
    Ital Heart J Suppl; 2001 Nov; 2(11):1240-2. PubMed ID: 11775418
    [Abstract] [Full Text] [Related]

  • 2. [Ticlopidine-induced cholestasis].
    Meyer MI, Kuhn M, Bühler H, Bertschinger P.
    Schweiz Med Wochenschr; 1999 Oct 02; 129(39):1405-9. PubMed ID: 10542998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH, Tsai SL, Chen TC, Liaw YF.
    J Formos Med Assoc; 2000 Nov 02; 99(11):866-9. PubMed ID: 11155780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ticlopidine-induced severe cholestatic hepatitis.
    Wu MS, Chan P, Lien GS, Cheng YS, Pan S.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug 02; 63(8):663-6. PubMed ID: 10969455
    [Abstract] [Full Text] [Related]

  • 7. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.
    Tsui PT, Lai ST, Leung WS, Mok NS, Wu CW, Lau ST, Choi YC.
    Hong Kong Med J; 2002 Feb 02; 8(1):57-9. PubMed ID: 11861996
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ticlopidine-induced cholestatic hepatitis.
    Skurnik YD, Tcherniak A, Edlan K, Sthoeger Z.
    Ann Pharmacother; 2003 Mar 02; 37(3):371-5. PubMed ID: 12639165
    [Abstract] [Full Text] [Related]

  • 10. [Cholestatic hepatitis as a rare side effect of therapy with ticlopidine].
    Berent R, Hinterholzer G, Höbling W, Auer J, Haidenthaler A, Knoflach P.
    Z Gastroenterol; 2000 Jul 02; 38(7):587-91. PubMed ID: 10965556
    [Abstract] [Full Text] [Related]

  • 11. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 02; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 12. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.
    Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST.
    Hong Kong Med J; 2005 Oct 02; 11(5):414-6. PubMed ID: 16219965
    [Abstract] [Full Text] [Related]

  • 13. Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
    Anselmino M, Moretti C, Ravera L, Sheiban I.
    Minerva Cardioangiol; 2010 Apr 02; 58(2):277-80. PubMed ID: 20440256
    [Abstract] [Full Text] [Related]

  • 14. Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?
    Jiménez-Quevedo P, Angiolillo DJ, Bernardo E, Sabaté M.
    Catheter Cardiovasc Interv; 2004 May 02; 62(1):39-42. PubMed ID: 15103601
    [Abstract] [Full Text] [Related]

  • 15. Delayed-onset ticlopidine-induced cholestatic jaundice.
    Kubin CJ, Sherman O, Hussain KB, Feinman L.
    Pharmacotherapy; 1999 Aug 02; 19(8):1006-10. PubMed ID: 10453975
    [Abstract] [Full Text] [Related]

  • 16. Possible ticlopidine-induced cholestatic jaundice.
    Wengrower D.
    Am Fam Physician; 2000 Sep 15; 62(6):1258, 1262. PubMed ID: 11011856
    [No Abstract] [Full Text] [Related]

  • 17. [Cholestatic hepatitis and anemia induced by ticlopidine].
    Pascual S, Sarrión JV, Jarque I, Argüello L, Berenguer J.
    Gastroenterol Hepatol; 1996 Apr 15; 19(4):208-9. PubMed ID: 8665360
    [Abstract] [Full Text] [Related]

  • 18. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
    Jeong YH, Park Y, Kim IS, Yun SE, Kang MK, Hwang SJ, Kwak CH, Hwang JY.
    Thromb Haemost; 2010 Dec 15; 104(6):1286-9. PubMed ID: 20838742
    [No Abstract] [Full Text] [Related]

  • 19. [Cholestatic hepatitis associated with ticlopidine].
    Bruguera M.
    Gastroenterol Hepatol; 1997 Mar 15; 20(3):163-4. PubMed ID: 9162540
    [No Abstract] [Full Text] [Related]

  • 20. [Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report].
    Kowalski R, Dropiński J, Brzostek T, Szot P, Rzeszutko M, Kasper M, Sawicka A, Szczeklik A.
    Kardiol Pol; 2008 Jul 15; 66(7):758-60. PubMed ID: 18690567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.